A randomized crossover trial found that wearable hip exoskeleton walking after meals significantly reduced glucose spikes in adults with type 2 diabetes compared with unassisted walking. The study frames the device as a post-prandial glucose intervention rather than a general activity replacement. For medtech and biotech convergence, it supports the growing clinical interest in wearable assisted mobility systems that can be deployed in structured daily contexts. It also helps define a measurable endpoint—post-meal glucose excursions—that may guide payer and clinical adoption. The results indicate that mechanical assistance could improve metabolic outcomes when timed to meals, a point relevant for digital therapeutics and device-guided care models.